S&P 5007,651.54▼0.2% Nasdaq26,861.06▲0.2% Dow50,906.05▼0.9% Russell 2K2,796.86▼0.4% 10-Yr5.29%+4bp VIX16.34+0.30 WTI$90.46▲1.2% Gold$4,189.00▲0.2% EUR/USD1.133▼0.3% BTC$86,432▲1.9% Nikkei65,481▼0.6%
At close · Wed, Sep 30, 2026
Daily Market Updates.

Global Markets

Home›Global Markets›China›Big Pharma expands China innovation deals as patent cl…

Big Pharma expands China innovation deals as patent cliff nears

Reported · Written up by our desk · China

CNBC World reports that Western biopharma companies are increasingly turning to China to source innovation as the industry’s “patent cliff” approaches.

The outlet says the trend is reflected in a new tie-up valued at up to $7.8 billion, as deal activity in China continues to grow.

← Newer storyU.S. employment report shows jobs gain slows to 29,000 in September

More like this

Global MarketsAirport Authority ends nearly 50-year deal over 11 Skies project
Global MarketsBig biopharma increasingly looks to China for new drugs
Global MarketsHong Kong IPO debuts slump as investor appetite fades
Global MarketsChina scientists report crop yield gains from mineralized irrigation water
Global MarketsHong Kong retail sales rise 5.6% year on year in August

Sources

CNBC WorldBig Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.